HTG MOLECULAR DIAGNOSTICS, INC (HTGM) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 261 transactions totaling $22.6M, demonstrating a bullish sentiment with $5.6M in net insider flow. The most recent transaction on Jun 8, 2023 involved a sale of 888 shares valued at $710.
No significant insider buying has been recorded for HTGM in the recent period.
No significant insider selling has been recorded for HTGM in the recent period.
Based on recent SEC filings, insider sentiment for HTGM is bullish with an Insider Alignment Score of 62/100 and a net flow of $5.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at HTG MOLECULAR DIAGNOSTICS, INC (HTGM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading HTGM stock, having executed 261 transactions in the past 90 days. The most active insider is Plc Glaxosmithkline (Executive), who has made 7 transactions totaling $11.2M.
Get notified when executives and directors at HTGM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 8, 2023 | Barat Stephen | Executive | Sale | 888 | $0.80 | $710 | |
| Mar 31, 2023 | Barat Stephen | Executive | Payment | 52 | $2.70 | $140 | |
| Dec 9, 2022 | Lee Godlewski Laura | Executive | Award | 1,000 | $0.43 | $430 | |
| Dec 9, 2022 | D. Mcmeans Shaun | Executive | Award | 1,000 | $0.43 | $430 | |
| Dec 9, 2022 | L. Lubniewski John | Executive | Award | 1,000 | $0.43 | $430 | |
| Dec 9, 2022 | Lawson Byron | Executive | Award | 1,000 | $0.43 | $430 | |
| Jun 30, 2022 | L. Lubniewski John | Executive | Payment | 61 | $1.03 | $63 | |
| Jun 30, 2022 | D. Mcmeans Shaun | Executive | Payment | 29 | $1.03 | $30 | |
| Jun 30, 2022 | Lawson Byron | Executive | Payment | 23 | $1.03 | $24 | |
| Jun 10, 2022 | Lawson Byron | Executive | Award | 1,000 | $0.48 | $480 | |
| Jun 10, 2022 | L. Lubniewski John | Executive | Award | 1,000 | $0.48 | $480 | |
| Jun 10, 2022 | D. Mcmeans Shaun | Executive | Award | 1,000 | $0.48 | $480 | |
| Jun 10, 2022 | Lee Godlewski Laura | Executive | Award | 1,000 | $0.48 | $480 | |
| Mar 31, 2022 | L. Lubniewski John | Executive | Payment | 62 | $1.39 | $86 | |
| Mar 31, 2022 | D. Mcmeans Shaun | Executive | Payment | 31 | $1.39 | $43 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 17 | $14.1M | 57.7% |
Sale(S) | 41 | $8.5M | 34.8% |
Other(J) | 37 | $1.4M | 5.9% |
Award(A) | 86 | $214.0K | 0.9% |
Payment(F) | 54 | $177.1K | 0.7% |
Conversion(C) | 25 | $0 | 0.0% |
Exercise (Options)(X) | 1 | $0 | 0.0% |
Insiders at HTG MOLECULAR DIAGNOSTICS, INC are accumulating shares at an accelerated pace. With 20 insiders making 261 transactions totaling $14.1M in purchases versus $8.5M in sales, the net buying activity of $5.6M signals strong executive confidence. Plc Glaxosmithkline (Executive) leads the buying activity with $11.2M in transactions across all time.